ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
0.54
-0.01
(-1.82%)
Closed September 25 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.54
Bid
0.49
Ask
0.55
Volume
2,500
0.54 Day's Range 0.55
0.48 52 Week Range 3.01
Previous Close
0.55
Open
0.54
Last Trade
500
@
0.54
Last Trade Time
Average Volume (3m)
36,282
Financial Volume
-
VWAP
-

DTC Latest News

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

 DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

  Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

 DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

  VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

  DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

    DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

 DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

 DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.011.886792452830.530.660.48287470.60785952CS
4-0.08-12.90322580650.620.660.48337480.56890888CS
12-0.26-32.50.80.960.48362820.70729147CS
26-1.16-68.23529411761.71.920.48378921.00654699CS
52-2.16-802.73.010.48282811.43285758CS
156-6.46-92.285714285777.10.48184012.43125495CS
260-1.21-69.14285714291.758.150.48181832.73751471CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
SNR79 Resources Ltd
$ 0.09
(100.00%)
5k
BHCCBlue Horizon Global Capital Corp
$ 0.01
(100.00%)
93k
CVGRCity View Green Holdings Inc
$ 0.01
(100.00%)
171k
DMEDDiagnamed Holdings Corp
$ 0.01
(100.00%)
4.5k
GGCGeneric Gold Corp
$ 0.105
(75.00%)
2k
CRPCCritical Reagent Processing Corp
$ 0.005
(-66.67%)
60k
VCTVelocity Data Inc
$ 0.02
(-63.64%)
21k
SPFYSpacefy Inc
$ 0.005
(-50.00%)
15k
LFNTLFNT Resources Corp
$ 0.025
(-50.00%)
4k
QMETQ Precious & Battery Metals Corp
$ 0.005
(-50.00%)
12.5M
QMETQ Precious & Battery Metals Corp
$ 0.005
(-50.00%)
12.5M
PAUProvenance Gold Corp
$ 0.115
(4.55%)
2.43M
VIKAvila Energy Corporation
$ 0.01
(0.00%)
1.88M
SNAStar Navigation Systems Group Ltd
$ 0.005
(0.00%)
1.65M
QIMCQuebec Innovative Materials Corp
$ 0.215
(13.16%)
1.62M

Your Recent History

Delayed Upgrade Clock